UKIPO rejects Novartis’s TM opposition attempt
18-06-2020
Indian drugmaker joins race to find COVID-19 vaccine
17-02-2020
J&J, HHS sign expanded deal to find COVID-19 vaccine
14-02-2020
Andrii Vodolazhskyi / Shutterstock.com
A consortium of life sciences companies including Novartis, Bristol Myers Squibb and GSK have united to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
COVID-19, coronavirus, Novartis, BMS, GSK, Gates Foundation, Wellcome Trust, vaccines, diagnostics, J&J, Pfizer, Sanofic
